← Back to all One Page Business Stories

The rise and fall of Theranos: From $9B valuation to criminal fraud

A 19-year-old dropout built a $9 billion blood-testing empire on lies — investors lost $945 million, and 945,000 patients got fake results.

By The Numbers

$9B
peak valuation
87%
test failure rate
$945M
investor losses total

What They Nailed Early

Holmes sold a compelling vision: replace painful blood draws and slow lab results with a single pin prick and instant diagnosis. She recruited a board of famous names — Kissinger, Mattis, Schultz — that gave instant credibility and opened doors to Walgreens and Safeway.

What Changed

The technology never worked. The Edison machine could run maybe one unreliable test while Theranos secretly used competitors' machines for real results. When employees like Tyler Schultz blew the whistle to the Wall Street Journal in 2015, the fraud unraveled. Federal regulators found the lab posed a threat to patient safety.

Where it Landed

Chapter 11 bankruptcy. Holmes sentenced to 11 years in prison. Balwani got 13 years. Investors lost $945 million. Nearly a million patients received voided test results. Company dissolved in 2018.

The Principles

1. 
Credibility theater isn't oversight. A board of famous names with zero domain expertise can't catch fraud — they just make it look legitimate.
2. 
Silicon Valley 'fake it till you make it' doesn't work in healthcare. When lives are at stake, optimism without proof is malpractice, not innovation.
3. 
Small lies compound into fraud. It starts with faking one demo, then forging partner logos, then running fake labs for the Vice President.

Builder's Takeaway

3 red flags that scream fraud, not innovation:
• 
No peer-reviewed studies after years of 'breakthroughs' — secrecy hides failure, not genius
• 
Board stacked with famous non-experts instead of scientists who can actually evaluate claims
• 
Aggressive NDAs and lawsuits to silence employees raising concerns about the product
Want the whole story? → Watch this on YouTube

More One Page Business Stories:

More